ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTURE
- 5 January 1985
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 325 (8419) , 30-34
- https://doi.org/10.1016/s0140-6736(85)90975-4
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous systemThe American Journal of Cardiology, 1982
- Angiotensin-converting enzyme inhibition and prostaglandinsThe American Journal of Cardiology, 1982
- Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levelsThe American Journal of Cardiology, 1982
- Role of kinins in the acute antihypertensive effect of the converting enzyme inhibitor, captopril.Hypertension, 1981
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension.Hypertension, 1980
- Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.BMJ, 1980
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979
- Relationships between the kallikrein-kinin and prostaglandin systemsLife Sciences, 1979
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977